Intravenous Antiplatelet Therapy May Improve Heart Function in Cardiogenic Shock Patients Compared to Oral Medication
November 09, 2026
November 09, 2026
NEW YORK, Nov. 9 [Category: BizHospital] -- Mount Sinai Health System posted the following news release:
* * *
Intravenous Antiplatelet Therapy May Improve Heart Function in Cardiogenic Shock Patients Compared to Oral Medication
*
Conference: American Heart Association Scientific Sessions 2026 (AHA 2026)
Presentation: Featured Science - "Multimodality Cardiac Imaging Substudy of the DAPT-SHOCK-AMI Randomized Trial: Echocardiog . . .
* * *
Intravenous Antiplatelet Therapy May Improve Heart Function in Cardiogenic Shock Patients Compared to Oral Medication
*
Conference: American Heart Association Scientific Sessions 2026 (AHA 2026)
Presentation: Featured Science - "Multimodality Cardiac Imaging Substudy of the DAPT-SHOCK-AMI Randomized Trial: Echocardiog . . .
